AHA 2022 · report-summary pathway
Pediatric ABPM Pathway
A transparent, clinician-facing comparison of a complete ambulatory BP report with a confirmed office-BP context.
What this test tool does—and does not do
It compares the six ABPM report means against the AHA 2022 pediatric thresholds, checks the quality metadata you attest to, and only then maps a confirmed office-BP context to a phenotype.
- It accepts a report summary—not raw monitor files, PDFs, images, home BP, cuffless readings, or a fixed nighttime clock window.
- For children under 13, it requires the validated report’s Wühl-based 95th-percentile limits, the height used, and the reference dataset. It never estimates or extrapolates them.
- BP load is deliberately excluded. Dipping is displayed as a descriptive calculation only and never changes the phenotype.
- Outpatient ages 5 to <18 only. Pregnancy, inpatient/acute settings, and active antihypertensive treatment require clinician-led interpretation outside this prototype.
1. Scope2. Quality gate3. Office bridge4. Means & thresholds5. Review prompt
Algorithm, sources, and release boundary
Version: AHA-2022-pediatric-ABPM-summary-v1.0. This test route is clinician-facing decision support, not an autonomous diagnosis system.
- AHA 2022 pediatric ABPM scientific statement: classification, quality conditions, diary-derived periods, and removal of BP load.
- AAP 2017 pediatric office-BP guideline: office-BP pathway context.
- Before any real clinical release: pediatric hypertension/nephrology review, blinded fixture comparison, privacy/security review, and regulatory review—especially before any raw monitor-file feature.